🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07532239
Starting soon Observational

Survey of Knowledge, Practice, and Recommendation Behaviors Regarding Healthy Lifestyles Among Healthcare Workers

NCT07532239 · tracked via the Priya Life Science China tracker
Sponsor
Jiangsu Taizhou People's Hospital
Phase
Observational
Started
2026-04-10
Last updated
2026-04-15

Condition(s) studied

Healthy LifestyleHealth KnowledgeHealth Behavior

Study summary

This cross-sectional observational study aims to assess healthy lifestyle knowledge, personal health practices, and lifestyle recommendation behaviors among healthcare workers across different levels of healthcare institutions. The study will also collect clinical examination and biochemical indicators to evaluate the health status of participants and explore their associations with lifestyle-related knowledge and behaviors.

Healthcare workers play a critical role in promoting healthy lifestyles among patients; however, their own health behaviors and recommendations may vary depending on training background and institutional settings. This study seeks to better understand these differences and identify potential gaps between knowledge and practice.

The findings of this study may help inform targeted training strategies and support the development of effective health promotion programs for healthcare professionals, ultimately improving the quality of lifestyle guidance provided to patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Healthcare workers employed at participating healthcare institutions Exclusion Criteria: * Individuals unwilling or unable to provide informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Taizhou People's Hospital Taizhou Jiangsu

More Jiangsu Taizhou People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07532239 on ClinicalTrials.gov ↗ ← All trials in China